Clinical trials: Biopsy Proven Non Small Cell Lung Cancer
Lung Cancer
Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in N2 Positive IIIA Non Small Cell Lung Cancer (NSCLC)
It is suggested that a bimodal or trimodal approach combining neoadjuvant chemotherapy with or without radiotherapy followed by surgery provides a potentially superior method of enhancing resectability and improving locoregional…
- Trial name
- NCT00452803
- Testing
- chemotherapy, Concurrent chemoradiation therapy
- Where
- South Korea
- Volunteers
- 102 people
- Sponsor
- National Cancer Center, Korea
Biopsy Proven Non Small Cell Lung Cancer, Head and Neck Cancer
A Volume, Motion, and Anatomically Adaptive Approach to Photon and Proton Beam Radiotherapy
This pilot study will determine changes over time in tumor volume/motion \& patient anatomy, as well as dose distributions to normal organs.
- Conditions
- Biopsy Proven Non Small Cell Lung Cancer, Head and Neck Cancer, Gastrointestinal Cancer, Colorectal Cancer
- Trial name
- NCT02130427
- Testing
- CT scan
- Where
- United States
- Volunteers
- 74 people
- Sponsor
- Abramson Cancer Center at Penn Medicine
Lung Cancer
Gefitinib in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer
RATIONALE: Gefitinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving Gefitinib before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be…
- Trial name
- NCT00616499
- Testing
- gefitinib, neoadjuvant therapy, therapeutic conventional surgery
- Where
- 4 sites in South Korea
- Volunteers
- 35 people
- Sponsor
- Yonsei University